Fear of Recurrence and Stopping Immunotherapy
NCT04761328
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The study includes participants experiencing distress with regard to stopping immunotherapy and will utilize cognitive-behavioral therapy to reduce fear of recurrence, depression, and anxiety and improve quality of life.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Cognitive Behavioral Therapy
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 21 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- University of Pittsburgh
- Last updated on ClinicalTrials.gov
- December 5, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Pennsylvania · 1
- UPMC Hillman Cancer Centers · Pittsburgh, PA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.